Literature DB >> 27228633

Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis?

Estrella Garcia-Gonzalez, Mauro Galeazzi, Enrico Selvi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27228633

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  4 in total

Review 1.  Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases.

Authors:  Amber Cintosun; Irene Lara-Corrales; Elena Pope
Journal:  Clin Drug Investig       Date:  2020-04       Impact factor: 2.859

2.  ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation.

Authors:  Dongxin Chen; Huirong Tang; Hongchao Jiang; Lei Sun; Wenjuan Zhao; Feng Qian
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

Review 3.  Cannabinoids in rheumatology: Friend, foe or a bystander?

Authors:  Nibha Jain; Arumugam Moorthy
Journal:  Musculoskeletal Care       Date:  2022-04-27

Review 4.  Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders.

Authors:  Ishtiaq Ahmed; Saif Ur Rehman; Shiva Shahmohamadnejad; Muhammad Anjum Zia; Muhammad Ahmad; Muhammad Muzammal Saeed; Zain Akram; Hafiz M N Iqbal; Qingyou Liu
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.